Evidence map›Paper›PMID 36071066›Full record

ArticleScientific reports2022

Spatio-temporal predictions of COVID-19 test positivity in Uppsala County, Sweden: a comparative approach.

Vera van Zoest, Georgios Varotsis, Uwe Menzel, Anders Wigren, Beatrice Kennedy, Mats Martinell, Tove Fall

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vera van ZoestDepartment of Information Technology, Uppsala University, P.O. Box 337, 751 05, Uppsala, Sweden. vera.van.zoest@it.uu.se.ORCID 0000-0002-3017-0874
Georgios VarotsisDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.
Uwe MenzelDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.
Anders WigrenDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.
Beatrice KennedyDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.ORCID 0000-0002-0066-4814
Mats MartinellDepartment of Public Health and Caring Sciences, Uppsala University, 751 22, Uppsala, Sweden.
Tove FallDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.ORCID 0000-0003-2071-5866

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous spatio-temporal COVID-19 prediction models have focused on the prediction of subsequent number of cases, and have shown varying accuracy and lack of high geographical resolution. We aimed to predict trends in COVID-19 test positivity, an important marker for planning local testing capacity and accessibility. We included a full year of information (June 29, 2020-July 4, 2021) with both direct and indirect indicators of transmission, e.g. mobility data, number of calls to the national healthcare advice line and vaccination coverage from Uppsala County, Sweden, as potential predictors. We developed four models for a 1-week-window, based on gradient boosting (GB), random forest (RF), autoregressive integrated moving average (ARIMA) and integrated nested laplace approximations (INLA). Three of the models (GB, RF and INLA) outperformed the naïve baseline model after data from a full pandemic wave became available and demonstrated moderate accuracy. An ensemble model of these three models slightly improved the average root mean square error to 0.039 compared to 0.040 for GB, RF and INLA, 0.055 for ARIMA and 0.046 for the naïve model. Our findings indicate that the collection of a wide variety of data can contribute to spatio-temporal predictions of COVID-19 test positivity.

Indexed as

COVID-19HumansSweden

Identifiers

PMID36071066
PMCPMC9450842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.